Moreover, knockdown of ACSL4, which prevents the formation of lipid rafts under RL treatment (Fig. 2M), abrogated the acquired resistance of melanoma cells to cisplatin (Fig. 3I). This evidence concerns the gene ACSL4 and melanoma.